id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-281703-6xwcxe8l	Di Altobrando, Ambra	Should SARS‐CoV‐2 influence immunosuppressive therapy for autoimmune blistering diseases?	2020-04-17		.txt	text/plain	999	56	43	In this dramatic period where the whole world is affected by the outbreak of coronavirus disease 19 (COVID‐19), scientific data relating to the causative virus SARS‐CoV‐2 as well as the subsequent therapeutic repercussions on the management of other diseases should be divulged in order to share as much information as possible among experts in a timely manner. In particular, we asked whether patients in immunosuppressive therapy Among possible trigger factors of autoimmune blistering diseases, immunization and viral infections are mentioned in the literature, although the underlying immunological mechanism is still unclear. 10 We hypothesize that the interruption of immunosuppressive therapy in autoimmune blistering disease patients may determine a dysregulation of inflammatory cytokines that not only exacerbates the bullous disease itself but may also be involved in the pathogenesis of the viral infection.	./cache/cord-281703-6xwcxe8l.txt	./txt/cord-281703-6xwcxe8l.txt